Ultra-brief digital help while waiting for psychotherapy
Official title: Optimizing a Digital Ultra-brief Treatment for Patients Waiting for Face-to-face Psychotherapy: An Investigation of Treatment Content, Human Support, and Patient Expectations (OPTIBRIEF)
Run by University of Bern · NCT07167849 · Data updated 2026-11-12
This trial tests different versions of a short online program (UKADO) to help adults with depression or anxiety who are waiting for outpatient psychotherapy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 312 (estimated) |
| Sponsor | University of Bern Academic / other |
| Locations | 1 site (Bern) |
| Status | Recruiting |
| Started | September 22, 2025 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | November 18, 2025 |
| Trial ID | NCT07167849 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with depressive or anxiety disorder diagnoses, a PHQ-ADS score ≥10, currently waiting for outpatient psychotherapy, fluent in German, and with internet access are ideal candidates.
✕Probably not a fit
People with acute suicidality, those already in psychotherapy or starting it within two weeks, or those without sufficient German skills or internet access are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
OPTIBRIEF uses a factorial randomized design to test three components of a digital ultra-brief intervention (UKADO): content focus (problem-focused vs resource-focused), human support (present vs absent), and expectation-fostering elements (present vs absent). After screening questionnaires and a diagnostic telephone interview (Mini-DIPS), participants are randomized into one of eight versions and complete the program in about 60 minutes, with instructions to continue the exercises afterward. Follow-up self-report questionnaires are collected at 2, 5, 9, and 24 weeks, and a subset of participants also completes a telephone interview about their experience. The trial requires internet access and German language skills and excludes people with acute suicidality or those already in or about to start psychotherapy within 14 days after randomization.
Why it matters
Potential benefit: If successful, the intervention could reduce anxiety and depressive symptoms during long waits for psychotherapy and improve coping while patients await formal treatment.
How similar studies have gone: Related guided and unguided digital interventions for depression and anxiety have shown modest symptom reductions, but ultra-brief formats and factorial component testing are relatively novel and less well-established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Read the patient information and return signed written informed consent sheet * Currently waiting for outpatient psychotherapy (self-report at baseline and assessed per telephone) * Age ≥ 18 (self-report at baseline and assessed per telephone) * Scoring equal to or above 10 on the PHQ-ADS (self-report at baseline) * Fulfilling diagnostic criteria of one or more of the following disorders assessed with the Diagnostic Short-Interview for Mental Disorders (Mini-DIPS, DSM-5 version; Margraf et al., 2017): Major Depressive Disorder, Persistent Depressive Disorder, Social Anxiety Disorder, Panic Disorder, Agoraphobia, Generalized Anxiety Disorder * Sufficient German skills (self-report at baseline) * Access to the internet (self-report at baseline) Exclusion Criteria: * Acute suicidality assessed during the telephone interview (Mini-DIPS) * Currently taking part in psychotherapy or a scheduled start of psychotherapy prior to the assessment 14 days post-randomization (assessed via self-report and during the DIPS telephone interview)
Where it's running
-
Department of Clinical Psychology and Psychotherapy, University of Bern
Bern, Switzerland Recruiting
Study contacts
- Principal investigator: Laura Luisa Bielinski, PhD — Department of Clinical Psychology and Psychotherpay, University of Bern
- Study coordinator: Laura Luisa Bielinski, PhD
- Email: laura.bielinski@unibe.ch
- Phone: +41 31 684 39 37
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Creating Health online course for people with rheumatological conditions
This project will test whether an online course about diet and self-care helps adults with rheumatoid arthritis, Sjogren's syndrome, lupus, mixed connective tissue disease, or psoriatic arthritis reduce fatigue and improve quality of life.
-
EGR2 and NLRP3 pathways in sleep apnea-related thinking and mood problems
This study will test whether activity in the EGR2 and NLRP3 inflammation pathways is linked to thinking, memory, and mood problems in children and adults with obstructive sleep apnea compared with healthy volunteers.
-
Blended (online + in-person) versus face-to-face transdiagnostic group therapy for anxiety and depression
This trial will try whether a blended program (online modules plus group sessions) helps adults with anxiety or depression as much as traditional face-to-face group therapy.
-
Understanding anxiety, depression, and bipolar disorder over time in China
This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.
-
See if personalized CBM-I can help anxious kids ages 10–17
Aimed at youth with Generalized, Separation, or Social Anxiety, the study tests a personalized cognitive bias modification for interpretation (CBM-I) to see if it reduces threat-focused thinking and anxiety.
-
Expectancy Focused Exposure for Anxiety Disorders
We test whether Expectancy Focused Exposure helps reduce anxiety symptoms and prevent fear from coming back better than Anxiety Focused Exposure in adults with anxiety disorders.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.